|
FNTA expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.136400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.837990E-01 |
| Normal-vs-Stage2 |
9.622400E-01 |
| Normal-vs-Stage3 |
1.267000E-01 |
| Normal-vs-Stage4 |
6.284000E-02 |
| Stage1-vs-Stage2 |
4.642200E-01 |
| Stage1-vs-Stage3 |
2.009900E-02 |
| Stage1-vs-Stage4 |
1.213880E-02 |
| Stage2-vs-Stage3 |
2.973000E-01 |
| Stage2-vs-Stage4 |
1.114960E-01 |
| Stage3-vs-Stage4 |
3.732400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.711200E-01 |
| Normal-vs-AfricanAmerican |
8.381800E-01 |
| Normal-vs-Asian |
9.909400E-01 |
| Caucasian-vs-AfricanAmerican |
9.987800E-01 |
| Caucasian-vs-Asian |
9.319200E-01 |
| AfricanAmerican-vs-Asian |
9.340200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.487800E-01 |
| Normal-vs-Female |
7.624400E-01 |
| Male-vs-Female |
4.909400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.986800E-01 |
| Normal-vs-Extreme_Weight |
5.659600E-01 |
| Normal-vs-Obese |
8.180000E-01 |
| Normal-vs-Extreme_Obese |
4.407800E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.631600E-01 |
| Normal_Weight-vs-Obese |
6.110200E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.206390E-01 |
| Extreme_Weight-vs-Obese |
4.942400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.145600E-02 |
| Obese-vs-Extreme_Obese |
7.055500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.514800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.057170E-01 |
| Normal-vs-Age(61-80Yrs) |
6.894400E-02 |
| Normal-vs-Age(81-100Yrs) |
7.542300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.249200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.635700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.696000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.771600E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.615600E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.610400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.333600E-01 |
| Normal-VS-Type2 PRCC |
1.222020E-01 |
| Normal-VS-KIRP CIMP |
3.805900E-02 |
| Normal-VS-Unclassified PRCC |
4.577400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.419430E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.014130E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.646800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.557170E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
7.387600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.311970E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.281180E-01 |
| Normal-vs-N1 |
1.344170E-02 |
| Normal-vs-N2 |
7.762000E-03 |
| N0-vs-N1 |
3.299000E-03 |
| N0-vs-N2 |
1.768490E-02 |
| N1-vs-N2 |
8.779200E-01 |
|
|
